Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANAB | SRPT | NRIX | ||
| Company | Anaptysbio Inc | Sarepta Therapeutics | Nurix Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 59.51 | 16.06 | 15.85 | ||
| High | 63.47 | 16.61 | 15.86 | ||
| Low | 55.51 | 15.99 | 15.04 | ||
| Latest | 57.28 | 16.23 | 15.22 | ||
| Change | -3.27 | +0.14 | -1.04 | ||
| % Change | -5.40% | +0.87% | -6.40% | ||
| Volume | 952,100 | 2,486,400 | 1,096,400 | ||
| 20-Day Average Volume | 496,425 | 2,403,900 | 838,295 | ||
| Previous Close | 60.55 | 16.09 | 16.26 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.04 | 17.68 | 15.92 | ||
| 20-Day Raw Stochastic | 62.96% | 13.09% | 9.05% | ||
| 20-Day Relative Strength | 59.39 | 38.24 | 41.48 | ||
| Weighted Alpha | +232.77 | -59.80 | +9.18 | ||
| Today's Opinion | 100% Buy | 88% Sell | 24% Buy | ||
| Previous Opinion | 100% Buy | 88% Sell | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 16% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.09% since 02/26/26 | -6.99% since 02/26/26 | -5.52% since 02/26/26 | ||
| Low | 52.68 on 03/03/26 | 15.70 on 03/04/26 | 15.04 on 03/05/26 | ||
| High | 63.47 on 03/05/26 | 17.26 on 02/27/26 | 16.45 on 03/04/26 | ||
| 1-Month | |||||
| %Chg | +19.58% since 02/05/26 | -4.70% since 02/05/26 | -4.58% since 02/05/26 | ||
| Low | 46.85 on 02/11/26 | 15.70 on 03/04/26 | 15.04 on 03/05/26 | ||
| High | 63.47 on 03/05/26 | 19.25 on 02/25/26 | 17.03 on 02/06/26 | ||
| 3-Month | |||||
| %Chg | +29.15% since 12/05/25 | -27.09% since 12/05/25 | -15.87% since 12/05/25 | ||
| Low | 42.00 on 01/06/26 | 15.70 on 03/04/26 | 15.04 on 03/05/26 | ||
| High | 63.47 on 03/05/26 | 24.68 on 01/26/26 | 22.50 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +161.55% since 09/05/25 | -13.25% since 09/05/25 | +53.58% since 09/05/25 | ||
| Low | 17.11 on 09/16/25 | 15.08 on 11/04/25 | 8.19 on 09/23/25 | ||
| High | 63.47 on 03/05/26 | 25.32 on 10/08/25 | 22.50 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,676,508 | 1,689,289 | 1,672,227 | ||
| Shares Outstanding, K | 27,688 | 104,990 | 102,843 | ||
| Annual Sales | 91,280,000 | 2,198,240,000 | 83,980,000 | ||
| Annual Net Income | -145,230,000 | -713,410,000 | -264,460,000 | ||
| Last Quarter Sales | 76,320,000 | 442,930,000 | 13,580,000 | ||
| Last Quarter Net Income | 15,110,000 | -412,230,000 | -78,220,000 | ||
| 60-Month Beta | 0.32 | 0.42 | 1.96 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.52 on 11/04/25 | -3.58 on 02/25/26 | -1.03 on 10/09/25 | ||
| Latest Earnings Date | 05/04/26 | 05/05/26 | 04/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||